Difference between revisions of "The Future of R&D in Pharmaceutical Industry in 2025"
Murat.akguc (talk | contribs) |
Ruthdonners (talk | contribs) m |
||
| Line 4: | Line 4: | ||
Peter Friedl<br> | Peter Friedl<br> | ||
Susan Liu<br> | Susan Liu<br> | ||
<br> | <br> | ||
'''Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to [mailto:ruthdonners@hotmail.com contact us].''' | '''Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to [mailto:ruthdonners@hotmail.com contact us].''' | ||
| Line 21: | Line 20: | ||
• [[Power of the United Nations]]<br> | • [[Power of the United Nations]]<br> | ||
• [[Legal Restrictions for Biotech increasing in certain countries, decreasing in others]]<br> | • [[Legal Restrictions for Biotech increasing in certain countries, decreasing in others]]<br> | ||
<br><br> | |||
'''Added new ones'''<br><br> | '''Added new ones'''<br><br> | ||
• [[IP rights]]<br> | • [[IP rights]]<br> | ||
| Line 31: | Line 30: | ||
• [[Increasing Competitiveness through innovation in biotechnology]]<br> | • [[Increasing Competitiveness through innovation in biotechnology]]<br> | ||
• [[Changing business models for pharmaceutical industry]]<br> | • [[Changing business models for pharmaceutical industry]]<br> | ||
<br><br> | |||
==Resources== | ==Resources== | ||
Revision as of 03:33, 19 September 2009
EMBA09 team:
Murat Akguc
Ruth Donners
Peter Friedl
Susan Liu
Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to contact us.
Scenarios.
To be added
Driving forces.
Edited existing ones
• Increasing potential to grow based on new available technology
• Struggling old world economy
• Increasing Empowerment of Consumers in Healthcare System
• Continuously growing demand for new medical applications
• The increasing gap between developed, emerging and poor economies
• The increasing globalization of markets
• Power of the United Nations
• Legal Restrictions for Biotech increasing in certain countries, decreasing in others
Added new ones
• IP rights
• Logistics/Distribution
• Illnesses of global importance/Pandemics
• Research budget in pharmaceutical industry
• Effect of development of health care system in emerging market countries to existing pharmaceutical industry
• Unification of regulatory approval
• Increasing Competitiveness through innovation in biotechnology
• Changing business models for pharmaceutical industry
Resources
- [1] Top Trends in Healthcare, Medicine and Pharmaceuticals - What's Next
- [2] 10 Major Healthcare / Pharmaceutical Trends -Jim Carroll's Blog
- [3] Pharma 2020: Virtual R&D "Which path will you take?" - PricewaterhouseCoopers